Cyanine2 NHS ester minimal dye

NHS esters Protein labeling

Cat. #	Quantity	Price	Lead time
1A041	5 nmol	$110	in stock
2A041	10 nmol	$140	in stock
3A041	25 nmol	$265	in stock

Found better price? Let us know and we will propose the way forward!

Cyanine2 minimal dye for protein labeling, an equivalent of Cy2® NHS ester minimal dye.

This reagent is specially quantified - each package contains specified amount of NHS ester with quantity variation within 10%.

Help center

What does "minimal" mean in Cyanine NHS ester minimal dye products, and can Cyanine2, Cyanine3, and Cyanine5 be mixed all together?

General properties

Appearance:	yellow solid
Mass spec M+ increment:	550.2
Molecular weight:	637.39
Molecular formula:	C₃₂H₂₈BF₄N₃O₆
Solubility:	soluble in polar organic solvents
Quality control:	NMR ¹H, HPLC-MS, functional testing
Storage conditions:	Storage: 12 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate.
MSDS:	Download
	Product specifications

Spectral properties

Excitation/absorption maximum, nm:	490
Emission maximum, nm:	510

Product citations

Miltner, N.; Kalló, G.; Csősz, É.; Miczi, M.; Nagy, T.; Mahdi, M.; Mótyán, J. A.; Tőzsér, J. Identification of SARS-CoV-2 Main Protease (Mpro) Cleavage Sites Using Two-Dimensional Electrophoresis and In Silico Cleavage Site Prediction. International Journal of Molecular Sciences, 2023, 24(4), 3236. doi: 10.3390/ijms24043236
McCarthy, K.P.; Go, D.B.; Senapati, S.; Chang, H.-C. An integrated ion-exchange membrane-based microfluidic device for irreversible dissociation and quantification of miRNA from ribonucleoproteins. Lab on a Chip, 2023, 23(2), 285-294. doi: 10.1039/d2lc00517d
Pletnev, P. I.; Shulenina, O.; Evfratov, S.; Treshin, V.; Subach, M. F.; Serebryakova, M. V.; Osterman, I. A.; Paleskava, A.; Bogdanov, A. A.; Dontsova, O. A.; Konevega, A. L.; Sergiev, P. V. Ribosomal Protein S18 Acetyltransferase RimI Is Responsible for the Acetylation of Elongation Factor Tu. Journal of Biological Chemistry, 2022, 298(5), 101914. doi: 10.1016/j.jbc.2022.101914
Ryabchevskaya, E. M.; Granovskiy, D. L.; Evtushenko, E. A.; Ivanov, P. A.; Kondakova, O. A.; Nikitin, N. A.; Karpova, O. V. Designing Stable Bacillus Anthracis Antigens with a View to Recombinant Anthrax Vaccine Development. Pharmaceutics, 2022, 14(4), 806. doi: 10.3390/pharmaceutics14040806

Show more (35)

Cy2® is a trademark of GE Healthcare.

Purchase of these products does not imply transfer of license to perform methods patented by Carnegie Mellon University and covered by US patents 6,043,025, 6,127,134, 6,246,190, 7566,544, and 7,598,047 "Difference gel electrophoresis using matched multiple dyes" and family members in Australia, Canada, Europe and Japan.

This Product is offered and sold for research purposes only. It has not been tested for safety and efficacy in food, drug, medical device, cosmetic, commercial or any other use. Supply does not express or imply authorization to use for any other purpose, including, without limitation, in vitro diagnostic purposes, in the manufacture of food or pharmaceutical products, in medical devices or in cosmetic products.